Home > Insider Trading > Filing (0000950142-10-000407)

Filing Details

Accession Number:: 0000950142-10-000407
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-10 12:00:00
Reporting Period:: 2010-03-08

Filing Date:: 2010-03-10
Accepted Time:: 2010-03-10 18:55:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401923	Map Pharmaceuticals Inc.	MAPP	Pharmaceutical Preparations (2834)	200507047

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
927752	H Frank Pearl	2099 Pennsylvania Avenue Nw Suite 900 Washington DC 20006		No	No	Yes	No
1253323	Perseuspur Llc	2099 Pennsylvania Ave Nw Ste 900 Washington DC 20006		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-08	5,000	$14.41	2,837,887	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2010-03-09	5,000	$15.21	2,832,887	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2010-03-10	3,925	$16.04	2,828,962	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.25 to $14.59. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"), Perseus-Soros Partners, LLC ("Perseus-Soros Partners"), the general partner of Perseus-Soros, Perseus Biotech Investment, LLC ("PBI"), Perseus Biotech Fund Partners, LLC ("Perseus Biotech Fund Partners"), Biotech Management Partners, LLC ("Biotech Management Partners"), Perseus, L.L.C. ("Perseus"), Perseuspur, L.L.C. ("Perseuspur"), Perseus 2000 Biotech Satellite, LLC ("Perseus Satellite") and Frank H. Pearl. Perseus BioTech Fund Partners is a managing member of Perseus-Soros Partners and Biotech Management Partners. Perseuspur is the managing member of Perseus, PBI, Perseus Biotech Fund Partners and the entity that controls Perseus Satellite. Frank H. Pearl is the managing member of Perseuspur.
Represents 5,000 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owned directly 8,925 shares of the Issuer's Common Stock.
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $15.00 to $15.50. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents 5,000 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owned directly 3,925 shares of the Issuer's Common Stock.
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $15.90 to $16.13. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents 3,925 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owns directly no shares of the Issuer's Common Stock, Perseus owns directly 2,792 shares of the Issuer's Common Stock, Frank H. Pearl owns directly 1 share of the Issuer's Common Stock and Perseus-Soros owns directly 2,826,169 shares of the Issuer's Common Stock.